Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tukaj, Stefan ^a   Kleszczyński, Konrad ^a   Vafia, Katerina ^a   Groth, Stephanie ^a   Meyersburg, Damian ^a   Trzonkowski, Piotr ^b   Ludwig, Ralf J ^a   Zillikens, Detlef ^a   Schmidt, Enno ^a   Fischer, Tobias W ^a   Kasperkiewicz, Michael ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN BP180; PROTEIN PHOSPHATASE 5; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BULLOUS PEMPHIGOID; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KERATINOCYTE; MALE; PEMPHIGUS VULGARIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UPREGULATION;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPIDERMIS; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84880798871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070496     Document Type: Article

References (39)

1. Schmidt E, Zillikens D, (2013) Pemphigoid diseases. Lancet 381: 320-32.
2. Kasperkiewicz M, Zillikens D, (2007) The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 33: 67-77.
3. Taipale M, Jarosz DF, Lindquist S, (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-28.
4. Srivastava P, (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2: 185-194.
5. Dello Russo C, Polak PE, Mercado PR, Spagnolo A, Sharp A, et al. (2006) The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem 99: 1351-62.
6. Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, et al. (2008) Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 58: 3765-75.
7. Yun TJ, Harning EK, Giza K, Rabah D, Li P, et al. (2011) EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity. J Immunol 186: 563-75.
8. Han JM, Kwon NH, Lee JY, Jeong SJ, Jung HJ, et al. (2010) Identification of gp96 as a novel target for treatment of autoimmune disease in mice. PLoS One 5: e9792.
9. Shimp SK 3rd, Chafin CB, Regna NL, Hammond SE, Read MA, et al (2012) Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol 9: 255-66.
10. Kasperkiewicz M, Müller R, Manz R, Magens M, Hammers CM, et al. (2011) Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. Blood 117: 6135-42.
11. Kleszczyński K, Fischer TW, (2012) Development of a short-term human full-thickness skin organ culture model in vitro under serum-free conditions. Arch Dermatol Res 304: 579-87.
12. Tukaj S, Kotlarz A, Jozwik A, Smolenska Z, Bryl E, et al. (2010) Hsp40 proteins modulate humoral and cellular immune response in rheumatoid arthritis patients. Cell Stress Chaperones 15: 555-66.
13. Schmidt E, Reimer S, Kruse N, Jainta S, Bröcker EB, et al. (2000) Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 115: 842-8.
14. Cheng CF, Fan J, Fedesco M, Guan S, Li Y, et al. (2008) Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 28: 3344-58.
15. Wang X, Song X, Zhuo W, Fu Y, Shi H, et al. (2009) The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 106: 21288-93.
16. Vidal Magalhães W, Gouveia Nogueira MF, Kaneko TM, (2012) Heat shock proteins (HSP): dermatological implications and perspectives. Eur J Dermatol 22: 8-13.
17. Jonak C, Klosner G, Trautinger F, (2009) Significance of heat shock proteins in the skin upon UV exposure. Front Biosci 14: 4758-68.
18. Wilson N, McArdle A, Guerin D, Tasker H, Wareing P, et al. (2000) Hyperthermia to normal human skin in vivo upregulates heat shock proteins 27, 60, 72i and 90. J Cutan Pathol 27: 176-82.
19. Nordlind K, (2002) Expression of heat shock proteins in heavy metal-provoked inflamed human skin. Immunopharmacol Immunotoxicol 24: 83-94.
20. Seung NR, Park EJ, Kim CW, Kim KH, Kim KJ, et al. (2007) Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. J Cutan Pathol 34: 903-11.
21. Ghoreishi M, Yokozeki H, Hua WM, Nishioka K, (2000) Expression of 27 KD, 65 KD and 72/73 KD heat shock protein in atopic dermatitis: comparison with those in normal skin and contact dermatitis. J Dermatol 27: 370-9.
22. Ghoreishi M, Katayama I, Yokozeki H, Nishioka K, (1993) Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases. J Dermatol 20: 400-5.
23. Bayramgürler D, Ozkara SK, Apaydin R, Erçin C, Bilen N, (2004) Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris. J Cutan Pathol 31: 586-94.
24. Ergun T, Ince U, Ekşioǧlu-Demiralp E, Direskeneli H, Gürbüz O, et al. (2001) HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 45: 904-9.
25. Jarvis M, Marzolini M, Wang XN, Jackson G, Sviland L, et al. (2003) Heat shock protein 70: correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. Transplantation 76: 849-53.
26. Berra A, Dutt JE, Nouri M, Foster CS, (1994) Heat shock protein expression in human conjunctiva. Invest Ophthalmol Vis Sci 35: 352-7.
27. Shimp SK 3rd, Parson CD, Regna NL, Thomas AN, Chafin CB, et al (2012) HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways. Inflamm Res 61: 521-33.
28. Yeo M, Park HK, Lee KM, Lee KJ, Kim JH, et al. (2004) Blockage of HSP 90 modulates Helicobacter pylori-induced IL-8 productions through the inactivation of transcriptional factors of AP-1 and NF-kappaB. Biochem Biophys Res Commun 320: 816-24.
29. Van den Bergh F, Eliason SL, Burmeister BT, Giudice GJ, (2012) Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8. Exp Dermatol 21: 605-11.
30. Dhillon V, McCallum S, Wilks D, Twomey B, Latchman D, et al. (1993) The differential expression of heat shock proteins in rheumatic disease. Br J Rheumatol 32: 883-92.
31. Ripley BJ, Isenberg DA, Latchman DS, (2001) Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90. J Autoimmun 17: 341-6.
32. Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, et al. (2007) Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27: 461-6.
33. Ludwig RJ, Schmidt E, (2009) Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? G Ital Dermatol Venereol 144: 339-49.
34. Erkeller-Yüksel FM, Isenberg DA, Dhillon VB, Latchman DS, Lydyard PM, (1992) Surface expression of heat shock protein 90 by blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun 5: 803-14.
35. Businaro R, Profumo E, Tagliani A, Buttari B, Leone S, et al. (2009) Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 207: 74-83.
36. Chandawarkar RY, Wagh MS, Kovalchin JT, Srivastava P, (2004) Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int Immunol 16: 615-624.
37. Liu Z, Li X, Qiu L, Zhang X, Chen L, et al. (2009) Treg suppress CTL responses upon immunization with HSP gp96. Eur J Immunol 39: 3110-3120.
38. De Filippo A, Binder RJ, Camisaschi C, Beretta V, Arienti F, et al. (2008) Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. J Immunol 181: 6525-35.
39. Cheng CF, Sahu D, Tsen F, Zhao Z, Fan J, et al. (2011) A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice. J Clin Invest 121: 4348-61.